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ABSTRACT
Objectives: To provide nationally representative data on
trends in HIV testing in primary care and to estimate the
proportion of diagnosed HIV positive individuals known to
general practitioners (GPs).
Methods: We undertook a retrospective cohort study
between 1995 and 2005 of all general practices
contributing data to the UK General Practice Research
Database (GPRD), and data on persons accessing HIV
care (Survey of Prevalent HIV Infections Diagnosed). We
identified all practice-registered patients where an HIV
test or HIV positive status is recorded in their general
practice records. HIV testing in primary care and
prevalence of recorded HIV positive status in primary care
were estimated.
Results: Despite 11-fold increases in male testing and
19-fold increases in non-pregnant female testing between
1995 and 2005, HIV testing rates remained low in 2005 at
71.3 and 61.2 tests per 100 000 person years for males
and females, respectively, peaking at 162.5 and 173.8 per
100 000 person years at 25–34 years of age. Inclusion of
antenatal tests yielded a 129-fold increase in women over
the 10-year period. In 2005, 50.7% of HIV positive
individuals had their diagnosis recorded with a lower
proportion in London (41.8%) than outside the capital
(60.1%).
Conclusion: HIV testing rates in primary care remain low.
Normalisation of HIV testing and recording in primary care
in antenatal testing has not been accompanied by a step
change in wider HIV testing practice. Recording of HIV
positive status by GPs remains low and GPs may be
unaware of HIV-related morbidity or potential drug
interactions.
HIV prevalence has increased in the UK over the
last decade with an estimated 73 000 individuals
living with HIV by 2006 of whom 21 000 remained
undiagnosed.1 HIV patients’ medical care has
historically been managed by stand-alone HIV
specialist services of which the larger provide some
primary care services.2 The number of HIV positive
individuals requiring these services has increased
threefold since the mid-1990s as a consequence of
new diagnoses and improved survival following the
introduction of highly active antiretroviral therapy
(HAART) around 1996.1 While HIV services can
ensure a high quality of HIV care for diagnosed
individuals, GPs report anecdotally that overall
clinical care may be compromised where a general
practitioner (GP) is unaware of their patient’s HIV
status and other treatments.3 There is evidence
that close liaison between specialist HIV services
and primary care can shorten admissions and
improve the standard of health care in this group
generally.4
Primary care remains a relatively under-used
resource for the delivery of sexual health services
other than contraception. England’s National
Strategy for Sexual Health and HIV proposes
enhancement of sexual health services in general
practice, including HIV testing, in order to reduce
high mortality rates among individuals diagnosed
late and to reduce transmission associated with
undiagnosed infection.5 Universal offer of HIV
testing to pregnant women began in 20006 as it
became clear that neonatal transmission is pre-
ventable and uptake of antenatal testing practi-
tioner-dependent.7 8 While the success of this
policy demonstrated the feasibility of HIV testing
in a non-specialist setting,9 no framework existed
for delivering HIV testing in the wider population
until recent recommendations for testing in pri-
mary care and in other health settings.10 11 Many
patients diagnosed with acute12 and established13
HIV infection consult prior to diagnosis in primary
care and often miss opportunities for earlier
diagnosis.
In this study we aimed to provide the first
nationally representative estimates of testing rates
and recording of positive HIV status in primary
care.
METHODS
Briefly, HIV testing rates and prevalence of
recorded HIV in primary care were estimated using
disaggregated data from a large primary care
database, the General Practice Research Database
(GPRD), broadly representative of the UK popula-
tion and containing 2.8 million current patients in
2005. Incidence of HIV testing in males, and
females with and without antenatal screening,
was estimated. The prevalence of recorded HIV
positive status in the GPRD was compared with a
denominator of all HIV positive individuals
reported to the surveillance dataset SOPHID
(Survey of Prevalent HIV Diagnosed). This allowed
us to estimate the proportion of all HIV positive
individuals whose status was coded in their general
practice record.
Population and sampling
The GPRD is a large anonymised primary care
database derived from computerised clinical
records produced during consultations in primary
Health services research
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care. It contains anonymised data on 4.7% (2.8 million in 2005)
of the UK population. The Medicines and Healthcare products
Regulatory Agency (MHRA) holds the licence for the database
and undertakes checks on the quality and completeness of data,
which have been collected continuously since 1988. The GPRD
is broadly demographically representative of the UK population,
although there is a slight under-representation of inner London
and Scotland. It has been used and validated for many
pharmacoepidemiological, epidemiological and public health
uses,14 with a denominator of 296 098 person-years of observa-
tion available to us for 2005. GPs enter medical diagnoses and
symptoms using Read codes15 or the similar but now superseded
Oxmis (Oxford Medical Information Systems) codes. Read and
Oxmis codes are alphanumeric hierarchical codes that have an
associated text description, which are used to summarise
information on diagnoses, symptoms, examination and referral
in UK primary care in coded form. Their scope is more diverse
than International Classification of Disease (ICD)-10 disease
codes and some are ambiguous (for example, ‘‘chlamydia’’) or
non-specific (‘‘unspecified chronic viral infection’’). In addition,
investigations, prescription data, and consultation data, age,
gender and Strategic Health Authority (SHA) of residence are
recorded for each registered individual.
Practice level quintiles of Index of Multiple Deprivation for
2004 (IMD 2004) score were used as a proxy for the level of
deprivation but ethnicity data were not available. Individual
level linkage to other datasets was not available.
We classified GPRD practices as rural or urban at super
output area level (a small area geographic boundary) in England,
Wales and Northern Ireland, and by NHS region in Scotland,
using data from national statistics providers.
Definitions of HIV testing and recorded HIV positive status
In total, 33 codes were identified denoting a definite HIV test
(see online supplementary material Appendix 1) and 61 codes
referring to HIV status, of which 56 codes denote a definite HIV
positive status (see online supplementary material Appendix 2
for details). Individuals who had any medical code recorded in
the GPRD denoting definite HIV positive status were subse-
quently defined as having recorded HIV positive status. An HIV
test was considered to be ‘‘antenatal’’ if it occurred within 6
months of any medical code indicating a current pregnancy.
Estimation of HIV testing rate in primary care
We estimated the incidence of HIV testing during the time
period 1995–2005 for males and females, including and
excluding antenatal tests, using the GPRD registered population
as denominator for person-years at risk. Survival analysis was
used to calculate person-years-of-exposure at risk of HIV
testing. Poisson regression was used to calculate 95% confidence
intervals (CIs) and incidence rate ratios (IRRs). Testing rates
(excluding antenatal tests) were estimated by age group, gender,
SHA, IMD and rural/urban category, and area of residence
(London vs outside London) for 2005.
We restricted counts of patients’ HIV test records to at most
one test in any 90 day period. HIV test events are often
duplicated in the GPRD due to the nature of data recording in
general practice. For example, a patient may have an HIV test in
general practice recorded in their medical records, while the
corresponding laboratory test result may be recorded in their
test records 2 weeks later. In addition, current surveillance from
specialist clinics reports only one test in each 3 month period.1
This approach also allows for one test only within the ‘‘window
period’’ of 90 days after exposure to HIV, which can be regarded
as a single episode of testing. Therefore, we have used the same
definition of a 3-month period to allow for comparisons with
other work. (Our data show that in 2005, 5.4% of all male and
2.2% of all female tests were recorded within this 90 day period
with little evidence of change over time.)
Recorded HIV positive individuals were removed from the
denominator for HIV testing incidence calculations as they are
no longer ‘‘at-risk’’ of HIV infection or testing.
Estimating the prevalence of HIV recorded in primary care
Prevalence of recorded HIV in primary care was calculated for
the years 1995–2005 for males and females with a more detailed
breakdown by age and demographic characteristics for 2005
only. The proportion of all diagnosed cases recorded in the
GPRD was estimated by comparing recorded prevalence in the
GPRD population as numerator, with age and sex-specific
reports to the SOPHID surveillance system (see below) as
denominator.
In the GPRD, prevalence of recorded HIV infections in general
practice was calculated using the number of patients registered
as at 30 June (mid-year) as the denominator. HIV infection is
most commonly diagnosed in genito-urinary medicine (GUM)
clinics or elsewhere in secondary care settings after which HIV
positive patients may or may not inform their GP.16 Practice
software allows separate recording of the date of a diagnosis and
the date of a first consultation relating to that diagnosis.
Therefore, the GPRD patient record may in some cases give two
different dates for first HIV diagnosis: an ‘‘event date’’ (for
example, the date on which the diagnosis was made elsewhere),
which could precede the ‘‘consultation date’’ (for example, date
of first consultation in primary care when HIV was discussed
and recorded by the GP). For this analysis we used the first date
on which HIV positivity was recorded in the primary care
record.
SOPHID is an annual survey of all persons attending at least
once for HIV care in specialist services across the UK and
represents the best available estimate of the diagnosed
prevalence of HIV in the UK.17 It was used as the denominator
from which to estimate the proportion of HIV cases recorded in
the primary care record. Individual anonymised data are
collected and analysed by the Health Protection Agency. Mid-
year population estimates were obtained from the UK’s Office
of National Statistics (ONS) as the denominator for UK HIV
prevalence estimates.
Other
For all analyses we defined the population of London as the five
pre-2006 SHAs with all other UK regions classed as outside the
capital using data provided by the ONS.
Data analysis was performed using STATA (version 9.0).
RESULTS
A total of 13.8 million person years of observation was available
for males and 13.9 million for females. We identified 28 447 HIV
tests in the GPRD during the study period 1995–2005. In 1995,
147 males and 45 females contributing data were recorded as
HIV positive by the end of the year and by 2005 this had risen to
776 and 413, respectively.
HIV testing in primary care
Figure 1 summarises trends in HIV testing during the study
period with rates for the age groups 16–44 and non-antenatal
Health services research
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testing shown separately. The period 1995–2005 saw an 11-fold
increase in HIV testing rates among males and a 129-fold
increase in all women reaching 514.5 per 100 000 women in
2005. However, when antenatal tests were excluded, the
increase among females reduced to 19-fold, and annual testing
rates remained lower in females (61.2 per100 000 person-years)
than in males (71.3 per100 000 person-years) in 2005 (exact
numbers are given in table 1 of the supplementary online
material).
Tables 1A and 1B show HIV testing by age, sex and
demographic characteristics. In 2005, testing incidence (exclud-
ing antenatal) among patients living in London was more than
double the rate seen elsewhere in the UK in both sexes (IRR 2.1;
95% CI 1.8 to 2.4) and 2.2 (95% CI 1.9 to 2.6) for males and
females, respectively. Outside London, testing rates were
highest among adults aged 25–34 in both sexes (156.2 and
162.3 per 100 000 person-years, respectively). However, in
London, testing was higher among both male and female adults
aged 35–44 years (263.9 and 271.9 per 100 000 person-years,
respectively). Among females testing varied by level of depriva-
tion with more testing in deprived settings. Individuals in non-
urban areas were less likely to test.
Prevalence of recorded HIV positive status in primary care and
how it compares with SOPHID data
Table 2 shows trends in the prevalence of recorded HIV positive
status in the GPRD, separately and as a proportion of SOPHID
cases. An estimated 50.7% (95% CI 47.9 to 53.7%) of HIV
positive individuals had their status recorded in coded form in
their primary care record in 2005—a proportion which changed
little in the period between 1995 and 2005. Prevalence of HIV
recorded in primary care increased in parallel with HIV
diagnosed prevalence in SOPHID, but the proportion of
diagnosed individuals having their HIV status recorded in
primary care remained relatively constant. Throughout, record-
ing remained lower in London than elsewhere, with the
proportion declining to 41.8% in 2005, by contrast with an
increase to 60.1% outside the capital city.
Table 3 shows estimates of recorded positive status by age,
sex and demographic characteristics in 2005. Recording was less
likely for men and women aged 25–34 years (36.4% males and
40.0% females) than older adults (61.0% males and 73.2%
females over 45 years) or children less than 16 years (table 3).
DISCUSSION
HIV testing increased substantially (11-fold in males and 19-fold
in non-pregnant females) in the primary care setting between
1995 and 2005. These increases were small in comparison with
increased antenatal testing.
Only half of all HIV positive individuals are recorded as such
in the primary care records. This proportion remained consis-
tently lower in London than elsewhere and did not change
despite rising prevalence over the decade.
This study provides the first nationally representative
estimates of testing rates and recording of positive HIV status
in primary care. Only a small proportion of HIV tests have
traditionally been taken in primary care. Chadborn and
colleagues estimated that 6.6% of tests in London and 13.0%
of tests outside London were taken in this setting in the decade
to 2000.16 A number of studies have confirmed that many late
presenters, who face increased mortality, have consulted in
primary care in the 12 months prior to diagnosis.18 19 Our data
demonstrate that while a large number of antenatal HIV tests
are routinely documented in primary care, expansion of
antenatal testing has not been accompanied by a wider step
change in testing patterns.
The steady rates of recording in primary care, during a period
in which HAART has transformed prognosis and increased
prevalence, are surprising, particularly in London. Lower
recording in London may relate to lower disclosure rates, to
patients’ difficulties in accessing primary care or fear of
disclosure among migrants who continue to form a high
Figure 1 HIV testing in general practice, all ages and ages 16–44 years by gender, and antenatal testing rates among females 16–44 years between
1995 and 2005 with 95% CI.
Health services research
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proportion of all HIV cases and are often resident in London.1
However, earlier studies demonstrated high rates of GP
registration and consultation even among these vulnerable
groups,20 21 and this does not fully explain the low recorded rates
seen in the capital. No data are available on patterns of
computerised coding practice for HIV in primary care and these
may have changed over time.
While benefiting from nationally representative data, our
study has a number of limitations. We may be underestimating
HIV testing and disclosure in primary care, particularly in earlier
years before widespread implementation of electronically
recorded laboratory results, which are more likely to lead to a
recorded test code than paper results. Antenatal testing may
also be underestimated since women can be tested elsewhere
(for example, a hospital or community antenatal visits) and
negative results may not appear in the primary care record. We
have not sought to match our estimates to antenatal HIV
testing surveillance for this reason. Not all cases of HIV
disclosed to GPs will be coded as such in the notes—
‘‘euphemism’’ codes such as ‘‘chronic viral illness’’ may be used,
information may be hidden in non-coded free text or not
recorded at all. Recorded HIV diagnoses are a combination of
HIV incidence and prevalence, with patients registering,
presenting and disclosing to GPs and then GPs entering this
onto the clinical record. Anecdotal information sought from GPs
during the study suggests that recording practice has been
variable but that precise coding is more likely in recent years.
We also cannot reliably determine a true ‘‘incident’’ date of
HIV diagnosis nor which cases were diagnosed in primary care.
Initial HIV positive tests from a laboratory are normally
notified to a GP by telephone for confirmatory testing (which
may then be conducted in GUM settings). These do not
automatically generate a coded entry and so cannot be
distinguished from cases diagnosed elsewhere.
Table 1A Rates (per 100 000 person-years) of HIV testing recorded in general practice in 2005 by age group, deprivation level and rural/urban
indicators, stratified by London versus outside of London, males
Covariate
London Outside London, UK
n
Rate (per 100 000
person year) IRR (95% CI) p Value n
Rate (per 100 000
person-year) IRR (95%CI) p Value
All 233 131.22 – – 811 63.02 – –
Level of deprivation
Quintile 1 (least deprived) 24 141.15 1 175 57.22 1
Quintiles 2–4 168 127.00 0.90 (0.59 to 1.38) 456 65.26 1.14 (0.96 to 1.36)
Quintile 5 (most deprived) 41 144.95 1.03 (0.62 to 1.70) 0.703 179 63.41 1.11 (0.90 to 1.36) 0.322
Rural/urban indicator
Urban 229 132.26 1 676 68.38 1
Intermediate 4 90.36 0.68 (0.25 to 1.84) 0.450 92 42.64 0.62 (0.50 to 0.77)
Rural NA NA NA 42 50.90 0.74 (0.54 to 1.02) ,0.001
Age group, years
,16 12 31.40 1 68 21.05 1
16–19 6 86.39 1.61 (0.96 to 2.71) 18 33.97 2.75 (1.03 to 7.33)
20–24 15 159.41 4.54 (3.18 to 6.48) 55 95.53 5.08 (2.38 to 10.85)
25–34 58 189.38 7.45 (5.69 to 9.77) 228 156.20 6.03 (3.24 to 11.23)
35–44 87 263.91 6.32 (4.84 to 8.26) 258 133.10 8.41 (4.60 to 15.37)
45+ 55 92.59 1.69 (1.28 to 2.24) ,0.001 183 35.64 2.95 (1.58 to 5.51) ,0.001
NA signifies ‘‘not applicable’’ since there are no areas in London classified as rural.
Table 1B Rates (per 100 000 person-years) of HIV testing recorded in general practice in 2005 by age group, deprivation level and rural/urban
indicators stratified by London versus outside of London, females, excluding antenatal tests
Covariate
London Outside London, UK
n
Rate (per 100 000
person-year) IRR (95% CI) p Value n
Rate (per 100 000
person-year) IRR (95% CI) p Value
All 212 117.64 – – 704 53.48 – –
Level of deprivation
Quintile 1 (least deprived) 21 114.81 1 135 43.15 1
Quintiles 2–4 142 105.08 0.92 (0.58 to 1.45) 411 57.18 1.32 (1.09 to 1.61)
Quintile 5 (most deprived) 49 182.96 1.59 (0.96 to 2.66) 0.004 158 55.51 1.29 (1.02 to 1.62) 0.016
Rural/urban indicator
Urban 207 117.80 1 587 58.14 1
Intermediate 5 111.45 0.95 (0.39 to 2.30) 0.903 90 40.60 0.70 (0.56 to 0.87)
Rural NA NA NA 27 31.77 0.55 (0.37 to 0.80) 0.001
Age group, years
,16 6 16.44 1 64 21.40 1
16–19 4 59.34 3.61 (1.02 to 12.79) 27 54.30 2.54 (1.62 to 3.98)
20–24 27 246.27 14.98 (6.19 to 36.29) 70 118.05 5.52 (3.93 to 7.74)
25–34 73 226.96 13.81 (6.01 to 31.74) 240 162.26 7.58 (5.76 to 9.99)
35–44 81 271.90 16.54 (7.22 to 37.91) 200 105.13 4.91 (3.71 to 6.51)
45+ 21 32.79 1.99 (0.81 to 4.94) ,0.001 103 18.07 0.84 (0.62 to 1.15) ,0.001
NA signifies ‘‘not applicable’’ since there are no areas in London classified as rural.
Health services research
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The lack of ethnicity data in the GPRD means that we cannot
reliably interpret the relationship between our findings and
recent demographic changes in the UK HIV epidemic. We were
not able to explore the extent to which non-recording is
concentrated in different ethnic groups and in particular among
black Africans who may have concerns about migration and
healthcare entitlements, which discourage disclosure to the GP.
Sexual orientation may not be known to the GP and we are
unable to estimate recording or testing rates among men who
have sex with men from our data. Finally, biases introduced by
under-representation of London practices cannot be accurately
assessed.
It is increasingly recognised in UK policy that normalisation
of HIV testing in primary care, on the scale already seen in the
context of antenatal care, will be required in order to reduce the
pool of undiagnosed prevalence,22 23 and national guidelines
Table 2 Prevalence of diagnosed HIV (SOPHID), HIV recorded in primary care (per 100 000 persons) and the proportion of HIV recorded in primary
care between 1995 and 2005 in London and outside London
Year
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
London
Numbers in SOPHID NA 8234 9252 10277 11531 12917 14505 16544 18824 20387 22228
Prevalence of
diagnosed HIV
(SOPHID) per
100 000 persons
NA 118.06 131.90 145.44 161.19 178.49 198.10 224.44 254.79 274.45 295.68
Numbers in GPRD 1 5 11 18 41 179 304 643 763 937 979
Prevalence of HIV
recorded in primary
care (GPRD) per
100 000 persons
43.12 42.24 47.92 52.50 60.10 84.56 78.66 88.04 101.40 113.48 123.43
95% CI, lower
bound
32.49 31.91 38.73 43.23 51.35 74.63 69.64 78.86 91.49 102.97 112.12
95% CI, upper
bound
56.13 54.86 58.64 63.17 69.91 95.44 88.53 97.99 112.10 124.77 135.58
% of HIV+ patients
whose status is
recorded in general
practice
NA 35.78% 36.33% 36.10% 37.29% 47.37% 39.71% 39.23% 39.80% 41.35% 41.75%
95% CI, lower
bound
NA 27.03% 29.36% 29.72% 31.86% 41.81% 35.15% 35.14% 35.91% 37.52% 37.92%
95% CI, upper
bound
NA 46.47% 44.46% 43.44% 43.37% 53.47% 44.69% 43.66% 44.00% 45.46% 45.85%
Outside London
Numbers in SOPHID NA 6629 6818 7746 8856 10107 12096 15258 18274 21790 25116
Prevalence of
diagnosed HIV
(SOPHID) per
100 000 persons
NA 12.95 13.29 15.07 17.19 19.57 23.36 29.37 35.03 41.58 47.67
Numbers in GPRD 88 124 68 122 225 1101 3715 5146 6759 7137 7759
Prevalence of HIV
recorded in primary
care (GPRD) per
100 000 persons
8.90 8.99 9.43 9.36 10.81 10.66 12.57 14.79 18.43 23.06 28.65
95% CI, lower
bound
7.47 7.62 8.08 8.07 9.48 9.38 11.22 13.33 16.80 21.25 26.64
95% CI, upper
bound
10.52 10.55 10.94 10.81 12.28 12.06 14.03 16.36 20.17 24.98 30.77
% of HIV+ patients
whose status is
recorded in general
practice
NA 69.44% 70.95% 62.14% 62.92% 54.46% 53.81% 50.35% 52.61% 55.46% 60.11%
95% CI, lower
bound
NA 58.81% 60.77% 53.53% 55.17% 47.94% 48.06% 45.39% 47.96% 51.10% 55.89%
95% CI, upper
bound
NA 81.44% 82.35% 71.75% 71.47% 61.61% 60.06% 55.70% 57.59% 60.09% 64.56%
The denominator used for the prevalence of diagnosed HIV (from SOPHID) was the estimated population mid-year provided by the Office of National Statistics.
The denominator used for the prevalence of HIV recorded (GPRD) was the number of patients registered mid-year.
Due to old geography codes and poor quality of the data in 1995, prevalence by region is not shown for this year.
Key messages
c Little is known about HIV testing in primary care, or the extent
of disclosure of HIV positivity to GPs, despite the importance
of early diagnosis.
c HIV testing rates in primary care increased slowly but
remained low in the decade to 2005 and were highest in
young adults.
c GPs test for HIV more in London and other urban areas.
c Less than half of all HIV positive individuals are recorded as
such by their GPs and with a lower proportion in London
where HIV is concentrated.
Health services research
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aimed at achieving this have recently been published.10 The
Center for Disease Control and Prevention (CDC) in the USA
recommends opt-out HIV testing for all adults attending any
healthcare facility, aimed at decreasing late presentation with
symptomatic HIV/AIDS and onward transmission.24 Given that
a third of HIV infected individuals are undiagnosed, and a third
of all those newly diagnosed present late in the course of their
infection,1 25 there is a need to expand HIV testing in primary
care as well as other healthcare settings.
Surveillance of HIV testing in the primary care setting is
essential to measure uptake and to ensure its feasibility,
acceptability and cost-effectiveness. Our data demonstrate the
feasibility of using large primary care databases to monitor
testing rates at national level. Further work is needed on the
mechanisms required to deliver increased HIV testing in
primary care. Detailed studies that explore barriers to the
recording of positive HIV status in primary care and its
relationship to the delivery of care to HIV positive individuals
could contribute to the planning of services for this group.
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